Page 145 - CW E-Magazine (27-5-2025)
P. 145

News from Abroad


       2,000 customers. Fengli  Group’s pri-  sales network centred  around inno-   The transaction  would create  pan-
       mary focus is on the pharma and health  vative excipients  and  active pharma   regional opportunities, enabling us  to
       product markets in mainland  China.  ingredients (APIs).           expand our principal  partnerships
       Their facilities  include an analytical                            beyond China and further solidify our
       pharma lab for product formulation and   Mr. Derk Jan Terhorst, Group CEO  regional presence.”
       support, as well as excipient research,   at Barentz, commented, “This envis-
       development and application labs.  aged acquisition would  mean a  trans-  Today, Barentz’s pharmaceutical
                                         formative step for Barentz in the Asia  and nutraceutical business  operates
          This intended strategic move would  Pacific  region,  and  fully  aligns  with  across seven Asian countries, supported
       grant Barentz access to the Chinese  our strategic  ambition  to expand and  by dedicated sales teams and a strong
       pharma market and establish a robust  strengthen our global presence.   technical focus.

       PETROCHEMICALS
       Univation offers 800,000-tpa design capacity

       for Unipol PE process technology


          Univation  Technologies, a part of                              package is immediately available from
       Dow, has announced the next-genera-                                Univation  Technologies and delivers
       tion of the Unipol PE process platform                             significant advantages for polyethylene
       with its newest world-scale  licensed                              producers seeking to build a new PE
       capacity offering of an 800,000 tonnes                             plant,” the company said.
       per annum (tpa) year design.
                                                                             Mr. Nathan  Wiker, President of
          In addition to investment advantages,                           Univation, commented, “With cracker
       the  800,000-tpa  design  maintains                                complexes becoming ever larger, the
       excellent polyethylene resin  pro-                                 development of this technology break-
       duct  flexibility  including  capability                           through responds to the industry’s clear
       for the manufacture of unimodal high-                              demand  for larger production  capaci-
       density polyethylene (HDPE), bimodal   This increased nameplate capacity  ties by offering improved configuration
       high-density polyethylene (bHDPE),  exceeds  Univation’s  previous  world-  options while building on the already
       linear low-density polyethylene (LLDPE),  scale nameplate capacity of 650,000-tpa.  proven significant capital and operating
       and metallocene PE (mPE) resin products,                           cost efficiencies and product flexibility
       the company said.                   “This new licensed process design  of the Unipol PE process.”
       NON-CORE ACTIVITY
       Synthomer divests its inorganic chemistry business


          UK-based  speciality chemicals  such as tin,  iodine,  copper, zinc  and  designated as non-core to the Group as
       firm,  Synthomer,  has  announced  an  tungsten for applications  in markets  part of the strategic review announced
       agreement to  divest  William Blythe  including life sciences, performance  in October 2022. “The business has
       Limited,  its inorganic chemistry busi-  coatings, polymers, electronics, cata-  limited  synergies with the rest of the
       ness, to its management team alongside  lysts and renewable energy. The busi-  Group  and its divestment will further
       H  Equity Partners, for consideration of  ness  has  approximately  85  employees  reduce the complexity of our site port-
        2
       £30-mn ($40-mn).  The sale proceeds  based at its UK manufacturing site in  folio and enhance our focus on higher
       will be used to reduce Group net debt.  Accrington, Lancashire.    value, higher growth speciality chemi-
                                                                          cals markets where  we  have strong
          Founded  in  1845,  William  Blythe   William  Blythe  is  part  of  Syntho-  and  sustainable leadership positions,”
       has pioneered the development and use  mer’s  Health & Protection and Per-  informed Synthomer’s CEO Mr. Michael
       of inorganic derivatives of elements  formance Materials division and was  Willome.


       Chemical Weekly  May 27, 2025                                                                   145


                                      Contents    Index to Advertisers    Index to Products Advertised
   140   141   142   143   144   145   146   147   148   149   150